Similar articles

• Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase, alanine aminopeptidase and lysozyme in patients with renal disease.

  Palmieri L, Ronca G, Cioni L, Puccini R. Palmieri L, et al. Contrib Nephrol. 1984;42:123-9. doi: 10.1159/000409971. Contrib Nephrol. 1984. PMID: 6152415 No abstract available.
• Stabilization of alanine aminopeptidase, gamma glutamyltranspeptidase, and N-acetyl-beta-D-glucosaminidase activity in normal urines.

  Mueller PW, MacNeil ML, Steinberg KK. Mueller PW, et al. Arch Environ Contam Toxicol. 1986 Jul;15(4):343-7. doi: 10.1007/BF01066400. Arch Environ Contam Toxicol. 1986. PMID: 2874775 No abstract available.
• [Urinary enzymes: early biochemical indicators in the biological monitoring study of subjects exposed to styrene].

  Malaguti Aliberti L, Severini GC. Malaguti Aliberti L, et al. Minerva Med. 1989 Apr;80(4):383-8. Minerva Med. 1989. PMID: 2566961 Italian.
• Urinary enzymes, nephrotoxicity and renal disease.

  Price RG. Price RG. Toxicology. 1982;23(2-3):99-134. doi: 10.1016/0300-483x(82)90092-0. Toxicology. 1982. PMID: 6126019 Review. No abstract available.
• The measurement of renal injury.

  Loeb WF. Loeb WF. Toxicol Pathol. 1998 Jan-Feb;26(1):26-8. doi: 10.1177/019262339802600103. Toxicol Pathol. 1998. PMID: 9502383 Review.